Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-10
2010-11-02
Wang, Shengjun (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07825143
ABSTRACT:
A method for controlling yeast-to-filamentous growth transition in fungi comprising contacting a fungal cell with an anti-fungal small molecule in an amount effective to reduce or inhibit the yeast-to-filamentous growth transition, wherein the anti-fungal small molecule is 5-(p-Bromobenzylidine)-α-isopropyl-4-oxo-2-thioxo-3-thiozolidineacetic acid or an analog thereof. A method for treating fungal infections comprising contacting one or more fungal cells with an anti-fungal small molecule in an amount effective to control the fungal infection, wherein the anti-fungal small molecule is 5-(p-Bromobenzylidine)-α-isopropyl-4-oxo-2-thioxo-3-thiozolidineactic acid or an analog thereof.
REFERENCES:
patent: 5834309 (1998-11-01), Thompson et al.
patent: 5955593 (1999-09-01), Korsmeyer
patent: 5981721 (1999-11-01), Mohan
patent: 6225335 (2001-05-01), Tang et al.
patent: 6562796 (2003-05-01), Baldwin et al.
patent: 6613889 (2003-09-01), Borders et al.
patent: 6706766 (2004-03-01), Yuan et al.
patent: 7144905 (2006-12-01), Yuan et al.
patent: 2003/0060663 (2003-03-01), Griffin et al.
patent: 2004/0266846 (2004-12-01), Yuan et al.
patent: 2006/0037091 (2006-02-01), Gurtner et al.
Nucci, M. and K.A. Marr, Emerging fungal diseases. Clin Infect Dis, 2005. 41(4): p. 521-6.
Pfaller, M.A. and D.J. Diekema, Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev, 2007. 20(1): p. 133-63.
Diezmann, S., et al., Phylogeny and evolution of medical species of Candida and related taxa: a multigenic analysis. J Clin Microbiol, 2004. 42(12): p. 5624-35.
Butler, G., et al., Evolution of pathogenicity and sexual reproduction in eightCandidagenomes. Nature, 2009. 459(7247): p. 657-62.
Fitzpatrick, D.A., et al., A fungal phylogeny based on 42 complete genomes derived from supertree and combined gene analysis. BMC Evol Biol, 2006. 6: p. 1-16.
D. Butler, O. All, J. Goffena, T. Loveless, T. Wilson, & K. Toenjes, The GRR1 gene ofCandida albicansis involved in the negative control of pseudohyphal morphogenesis, Fungal Genetics and Biology, 2006, pp. 573-582, vol. 43, Elsevier, Amsterdam, The Netherlands.
N. Fedorova, J. Badger, G. Robson, J. Wortman, & W. Nierman, Comparative analysis of programmed cell death pathways in filamentous fungi, BMC Genomics, 2005, pp. 1-14, vol. 6, Fedorova, London, United Kingdom.
D. Warnock, Trends in the Epidemiology of Invasive Fungal Infections, Japan Journal of Medical Mycology, 2006, pp. 1-12, vol. 48, Shun Kosha Inc., Tokoyo, Japan.
F. Madeo, E. Herker, C. Maldener, S. Wissing, S. Lachelt, M. Herlan, M. Feher, K. Lauber, S. Sigrist, S. Wesselborg, & K. Frohlich, A Caspase-Related Protease Regulates Apoptosis in Yeast, Molecular Cell, 2002, pp. 911-917, vol. 9, Cell Press, Cambridge, MA USA.
S. Saville, A. Lazell, C. Monteagudo, & J. Lopez-Ribot, Engineered Control of Cell Morphology in Vivo Reveals Distinct Roles for Yeast and Filamentous Form ofCandida albicansduring infection, Eukaryotic Cell, 2003, pp. 1053-1060, vol. 0.4, American Society for Microbiology, Washington, DC USA.
H. Lo, J. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, & G. Fink, NonfilamentousC. albicansMutants are Avrulent, Cell, 1997, pp. 939-949, vol. 90, Cell Press, Cambridge, MA USA.
R. S. Care, J. Trevethick, K. M. binley, & P. E. Sudbery, The MET3 promoter: a new tool forCandida albicansmolecular genetics, Molecular Microbiology, 1999, pp. 792-798, vol. 34/4, Blackwell Science Ltd., Malden, MA USA.
M. Edmond, S. Wallace, D. McClish, M. Pfaller, R. Jones, & R. Wenzel, Nosocomial Bloodstream Infections in the United States Hospitals : A three-year Analysis, Clinical Infectious Diseases, 1999, pp. 239-244, vol. 29, Infectious Disease Society of America, Arlington, VA USA.
Butler David K.
Toenjes Kurt A.
Montana State University - Billings
Tease Antoinette M.
Wang Shengjun
LandOfFree
Method for controlling the yeast-to-filamentous growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for controlling the yeast-to-filamentous growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for controlling the yeast-to-filamentous growth... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4211694